In addition, group B (HOMA-IR ≥ 2.5) had significantly more preoperative biomarker abnormalities (other than dyslipidemia) than group A, including leptin, ghrelin, PYY, insulin, RBP4, and LGr (Table 3). This evidence concerns the gene INS and metabolic syndrome.